Pharmacists in Warminster, Pennsylvania


46 Pharmacists found in Warminster
female pharmacist

Niju Varughese, RPH


Pharmacist
100 Veterans Way, Warminster, PA 18974
215-347-1951    

female pharmacist

Dr. Preeti Philip, PHARMD


Pharmacist
10 York Rd, Warminster, PA 18974
215-956-2834     215-956-3772

male pharmacist

Richard T Kuk, RPH


Pharmacist
1535 W Street Rd, Warminster, PA 18974
215-442-1300     215-442-1301



female pharmacist

Rosa Marina Romero-aguilar


Pharmacist
7 York Rd, Warminster, PA 18974
215-443-8113    

female pharmacist

Dr. Safaknur Balat, PHARMD


Pharmacist
100 Veterans Way, Warminster, PA 18974
215-347-1951    

male pharmacist

Sean Deegan


Pharmacist
10 York Rd, Warminster, PA 18974
215-956-2834    

female pharmacist

Simi Mathew


Pharmacist
7 York Rd, Warminster, PA 18974
215-443-8113    

female pharmacist

Dr. Sophia Annette Crossin, PHARMD


Pharmacist
445 W Street Rd, Warminster, PA 18974
215-674-2297    

male pharmacist

Stefan Mishchuk, PHARM.D.


Pharmacist
7 York Rd, Warminster, PA 18974
215-443-8113    

female pharmacist

Dr. Sumera K Kazim, PHARMD


Pharmacist
100 Veterans Way, Warminster, PA 18974
215-347-1950    

female pharmacist

Tatyana Berman, PHARMD


Pharmacist
7 York Rd, Warminster, PA 18974
215-443-8113    

female pharmacist

Ms. Victoria Dukhovny, ROTH


Pharmacist
455 W Street Rd, Warminster, PA 18974
267-243-2502    

male pharmacist

Waymond Zhou, PHARMD


Pharmacist
7 York Rd, Warminster, PA 18974
215-443-8113    

female pharmacist

Wendi Glavicic, RPH


Pharmacist
375 W Street Rd, Warminster, PA 18974
215-956-9280    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.